We have shown before that KCa3.1 channel activity is lower in CD8+ cells isolated from head and neck cancer (HNC) patients’ blood: it could be attributed to the reduced calmodulin expression or inhibition of adenosine through adenosine receptor A2A [13,19,24,25]. This evidence concerns the gene ADORA2A and head and neck cancer.